Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
Join the waitlist to be notified when we launch
Note: Researchers may also be interested in the CJC-1295 no DAC / Ipamorelin Blend, commonly studied for its role in growth hormone regulation without the extended half-life of DAC
Even more so, their levels of GLP-1 increased
First, it acts as a vehicle of copper, an element essential for multiple enzymes responsible for connective tissue formation, antioxidant activity, and cellular respiration
US$ 20.88
US$ 25.56
US$ 20.13
